RAP-261

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRAP-261
Drug Alias NameRAP-261
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAutistic Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRapid Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRapid Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsAutistic Disorder

Other Information

ATC CodeN/A
Related LinksN/A